<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>211(10)</volume><submitter>Eller MA</submitter><funding>Intramural NIH HHS</funding><pubmed_abstract>&lt;h4>Background&lt;/h4>Untreated human immunodeficiency virus type 1 (HIV) infection is associated with persistent immune activation, which is an independent driver of disease progression in European and United States cohorts. In Uganda, HIV-1 subtypes A and D and recombinant AD viruses predominate and exhibit differential rates of disease progression.&lt;h4>Methods&lt;/h4>HIV-1 seroconverters (n = 156) from rural Uganda were evaluated to assess the effects of T-cell activation, viral load, and viral subtype on disease progression during clinical follow-up.&lt;h4>Results&lt;/h4>The frequency of activated T cells was increased in HIV-1-infected Ugandans, compared with community matched uninfected individuals, but did not differ significantly between viral subtypes. Higher HIV-1 load, subtype D, older age, </pubmed_abstract><journal>The Journal of infectious diseases</journal><pagination>1574-84</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4425824</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>HIV Type 1 Disease Progression to AIDS and Death in a Rural Ugandan Cohort Is Primarily Dependent on Viral Load Despite Variable Subtype and T-Cell Immune Activation Levels.</pubmed_title><pmcid>PMC4425824</pmcid><pubmed_authors>Opollo MS</pubmed_authors><pubmed_authors>Eller LA</pubmed_authors><pubmed_authors>Gray RH</pubmed_authors><pubmed_authors>Eller MA</pubmed_authors><pubmed_authors>Milazzo M</pubmed_authors><pubmed_authors>Liu M</pubmed_authors><pubmed_authors>Sewankambo NK</pubmed_authors><pubmed_authors>Kiwanuka N</pubmed_authors><pubmed_authors>Serwadda D</pubmed_authors><pubmed_authors>Laeyendecker O</pubmed_authors><pubmed_authors>Wabwire-Mangen F</pubmed_authors><pubmed_authors>Sandberg JK</pubmed_authors><pubmed_authors>Quinn TC</pubmed_authors><pubmed_authors>Kityo C</pubmed_authors><pubmed_authors>Kayiwa J</pubmed_authors><pubmed_authors>Wawer MJ</pubmed_authors><pubmed_authors>Redd AD</pubmed_authors><pubmed_authors>Robb ML</pubmed_authors><pubmed_authors>Michael NL</pubmed_authors></additional><is_claimable>false</is_claimable><name>HIV Type 1 Disease Progression to AIDS and Death in a Rural Ugandan Cohort Is Primarily Dependent on Viral Load Despite Variable Subtype and T-Cell Immune Activation Levels.</name><description>&lt;h4>Background&lt;/h4>Untreated human immunodeficiency virus type 1 (HIV) infection is associated with persistent immune activation, which is an independent driver of disease progression in European and United States cohorts. In Uganda, HIV-1 subtypes A and D and recombinant AD viruses predominate and exhibit differential rates of disease progression.&lt;h4>Methods&lt;/h4>HIV-1 seroconverters (n = 156) from rural Uganda were evaluated to assess the effects of T-cell activation, viral load, and viral subtype on disease progression during clinical follow-up.&lt;h4>Results&lt;/h4>The frequency of activated T cells was increased in HIV-1-infected Ugandans, compared with community matched uninfected individuals, but did not differ significantly between viral subtypes. Higher HIV-1 load, subtype D, older age, </description><dates><release>2015-01-01T00:00:00Z</release><publication>2015 May</publication><modification>2025-04-19T02:55:09.934Z</modification><creation>2019-03-27T01:51:18Z</creation></dates><accession>S-EPMC4425824</accession><cross_references><pubmed>25404522</pubmed><doi>10.1093/infdis/jiu646</doi></cross_references></HashMap>